A WeChat mini-program-based approach to smoking cessation behavioral interventions: Development and preliminary
Shuilian Chu1, Lin Feng1, Hang Jing1
1Department of Research on Tobacco Dependence Therapies, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
This study developed the WQ mini-program, a WeChat tool for smoking cessation interventions. The program showed high usability and acceptability, with 50% of Chinese smokers achieving abstinence after 4 weeks.
Area of Science:
- Digital Health
- Behavioral Science
- Public Health
Background:
- Smoking remains a significant public health issue globally.
- Digital interventions offer scalable solutions for smoking cessation.
- WeChat mini-programs present a novel platform for health interventions in China.
Purpose of the Study:
- To develop and evaluate the WQ mini-program, a WeChat-based tool for smoking cessation behavioral interventions.
- To assess the usability, acceptability, and preliminary efficacy of the WQ mini-program among Chinese smokers.
Main Methods:
- The WQ mini-program was developed using behavioral change theories and expert clinical input.
- A single-arm trial involved 50 Chinese smokers and 5 software experts over 4 weeks.
- Usability and acceptability were measured using the System Usability Scale (SUS) and Mobile App Rating Scale (MARS).
- Preliminary efficacy was assessed via self-reported 7-day point prevalence abstinence (PPA).
Main Results:
- Smokers reported high usability (SUS: 82.1 ± 13.8) and acceptability (MARS: 84.5 ± 3.3) of the WQ mini-program.
- 95.8% of smokers intended to continue using the program, and 85.4% would recommend it.
- The 4-week self-reported 7-day PPA was 50% (25/50) among participating smokers.
Conclusions:
- The WQ mini-program is a feasible and potentially effective tool for smoking cessation among Chinese smokers.
- High user satisfaction and willingness to recommend suggest strong potential for adoption.
- Further validation through randomized controlled trials is recommended to confirm efficacy.
More Related Videos
06:12Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
Published on: March 3, 2023
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
Related Concept Videos
Behavior Modification
A real-world application of operant conditioning principles is applied...
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Operant Conditioning Intervention
In operant conditioning, behaviors that are...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
